Пошуковий запит: (<.>U=Р569.695.4$<.>) |
Загальна кількість знайдених документів : 251
Представлено документи з 1 до 20
|
| | |
| 1. |
Semko S. A case of synchronous bilateral calyx urothelial carcinoma: combined treatment approach // Experimental Oncology. - 2019. - 41, № 1.
|
| 2. |
Mytsyk Yu. O. A role of microRNAs in pathogenesis of renal cell carcinoma : (a rev.) // Експерим. та клініч. фізіологія і біохімія. - 2017. - № 3.
|
| 3. |
Rymar V. I. Aberrant expression of metallothioneins in clear cell renal cell carcinomas // Biopolymers and Cell. - 2015. - 31, № 6.
|
| 4. |
Rudenko E. Aberrant expression of selenium-containing glutathione peroxidases in clear cell renal cell carcinomas // Эксперим. онкология. - 2015. - 37, № 2.
|
| 5. |
Dudkowska M. Active Akt/PKB kinase and c-Myc transcription factor are up-regulated in anticancer drug-injured mouse kidney // Укр. біохім. журн.. - 2005. - 77, № 2 [спец. вип.].
|
| 6. |
Volkogon A. D. Analysis of ANRIL gene polymorphism rs4977574 association with kidney cancer development in Ukrainian population // Мед. перспективи. - 2020. - 25, № 2.
|
| 7. |
Campanella L. Analytical chemical considerations on tumor genesis. — 2001 // Эксперим. онкология.
|
| 8. |
Volkogon A. Association of MALAT1 rs3200401 gene polymorphism with kidney cancer in Ukrainian population // Eastern Ukr. Med. J. - 2019. - 7, № 2.
|
| 9. |
Volkogon A. Association of MALAT1 rs3200401 gene polymorphism with kidney cancer in Ukrainian population // Eastern Ukr. Med. J. - 2019. - 7, № 2.
|
| 10. |
Kondratov A. G. Determination of the mechanism of FHIT gene inactivation in clear cell renal carcinomas // Biopolymers and Cell. - 2009. - 25, № 5.
|
| 11. |
Rudenko E. E. Genetic and epigenetic changes of GPX1 and GPX3 in human clear-cell renal cell carcinoma // Biopolymers and Cell. - 2013. - 29, № 5.
|
| 12. |
Di Micco B. HCV and renal cell carcinoma: a new insight between HCV and oncogenesis? Report of five cases. — 2003 // Эксперим. онкология.
|
| 13. |
Rudenko E. E. Heterozygous deletions are main cause of expression alterations of PPM1M and PRICKLE2 genes in human clear cell renal cell carcinomas // Biopolymers and Cell. - 2015. - 31, № 1.
|
| 14. |
Chaves K. C. B. Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma // Experimental Oncology. - 2018. - 40, № 1.
|
| 15. |
Zonov E. V. Influence of polychemotherapy on the morphology of metastases and kidney of resistant RLS-bearing mice // Эксперим. онкология. - 2013. - 35, № 1.
|
| 16. |
Giannakopoulos X. Ipsilateral adrenalectomy for renal cell carcinoma: mandatory standard procedure or overtreatment?. — 2003 // Эксперим. онкология.
|
| 17. |
Sernyak Y. P. Life quality of patients with renal cell carcinoma after tumor resection // Здоровье мужчины. - 2013. - № 4.
|
| 18. |
Dumanskiy Y. V. Markers of epithelial-mesenchymal transition in renal cell carcinoma // Эксперим. онкология. - 2013. - 35, № 4.
|
| 19. |
Stroi A. A. MicroRNA-508-3р level in the blood of kidney cancer patients // Здоровье мужчины. - 2017. - № 3.
|
| 20. |
Строй О. О. Padua Score у хірургічному SRV // Урологія. - 2013. - 17, № 3.
|
| | |
НОВІ
ПОШУК
Книжкові видання та компакт-диски
